Law360, New York (October 08, 2009, 6:13 PM ET) -- Teva Women’s Health Inc. has filed a patent infringement suit against Lupin Ltd. over its plans to market a generic version of Seasonale, an oral contraceptive that limits the number of menstrual periods women have in a year.
Teva lodged the suit Tuesday in the U.S. District Court for the District of New Jersey, claiming that Lupin had filed an abbreviated new drug application with the U.S. Food and Drug Administration for a generic version of the contraceptive in August.
The patent-in-suit, U.S. Patent Number RE29,861,...
Teva Slaps Lupin With Patent Suit Over Seasonale
To view the full article, take a free trial now.
